New once-daily, long-acting inhaled β2-agonist: what role will it play in the treatment of chronic obstructive pulmonary disease?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 1, 2010
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Administration, Inhalation (MeSH)
- Adrenergic beta-Agonists (MeSH)
- Bronchodilator Agents (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Humans (MeSH)
- Pulmonary Disease, Chronic Obstructive (MeSH)
- Treatment Outcome (MeSH)